Aruvant to Participate in Numerous Scientific and Investor Conferences in February and March
Press release content from PR Newswire. The AP news staff was not involved in its creation. Aruvant to Participate in Numerous Scientific and Investor Conferences in February and March February 11, 2021 GMT (PRNewsfoto/Aruvant Sciences) NEW YORK and BASEL, Switzerland, Feb. 11, 2021 /PRNewswire/ -- Aruvant, a clinical-stage biopharmaceutical company focused on developing and commercializing transformative gene therapies for the treatment of rare diseases, today announced management participation in multiple investor and scientific conferences in February and March. The company will be at the ...